Octahydropyrido[1,2-alpha]pyrazines as MAGL inhibitors
US-11608347-B2 · Mar 21, 2023 · US
This patent family groups 2 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 65200769 |
| Family type | — |
| Earliest priority | Jan 8, 2018 |
| First filing country | US |
| Member publications | 2 |
| Countries | US |
| Representative publication | US11608347B2 — Octahydropyrido[1,2-alpha]pyrazines as MAGL inhibitors |
Best representative member for this family based on priority and filing country.
US11608347B2 — Octahydropyrido[1,2-alpha]pyrazines as MAGL inhibitors (published Mar 21, 2023)
Related publications in this family.
US-11608347-B2 · Mar 21, 2023 · US
US-2021024546-A1 · Jan 28, 2021 · US